Board of Directors

	David Blackett (Treasurer) Vice President of Marketing and Strategy PerkinElmer ViaCord Waltham, Massachusetts 2014-2021
	Jaap Jan Boelens, MD, PhD Pediatrician – Oncologist/Immunologist University Medical Center Utrecht Utrecht, The Netherlands 2016-2020
	Haywood Brown, MD Chair, Obstetrics and Gynecology Duke University School of Medicine Durham, North Carolina 2014-2021
	Deepak Chhabra, BSc, DBM Chief Executive Officer StemCyte India Gandhinagar, Gujarat, India 2016-2018
	Calvin Cole President/Chief Executive Officer CariCord Irvine, California 2016-2021
	Salmaan Dalvi, PhD Director of Cord Blood and Stem Cell Programmes Precious Cells Uxbridge, United Kingdom 2016-2018
	Colleen Delaney, MD, MSc Director, Program in Cord Blood Research and Transplantation Fred Hutchinson Cancer Research Center Seattle, Washington 2014-2020
	Arthur Flatau, PhD Patient Advocate Bone Marrow Transplant Survivor Austin, Texas 2014-2019
	Kenneth Giacin, MS, MBA (Vice President) Vice Chairman and Chief Business Officer StemCyte International Baldwin Park, California 2014-2018
	Nicholas Grund, MBA Executive Vice President & Chief Commercial Officer AMAG Pharmaceuticals San Bruno, California 2017-2020
	Joanie Y. Hare, MD Maternal Fetal Medicine Houston Perinatal Associates Houston, Texas 2016-2019
	Elaine Hsieh Chair and Chief Executive Officer Sino Cell Technologies Taipei, Taiwan 2017-2019
	Gesine Koegler, PhD (Secretary) Jose Carreras Cord Blood Bank and GMP Facility Director University of Duesseldorf Medical Center Duesseldorf, Germany 2014-2020
	Joanne Kurtzberg, MD (President) Director Carolinas Cord Blood Bank Durham, North Carolina 2014-2019
	Aby J. Mathew, PhD Senior Vice President & Chief Technology Officer BioLife Solutions, Inc. Bothell, Washington 2014-2021
	Mahendra Rao, MBBS, PhD Vice President for Regenerative Medicine New York Stem Cell Foundation New York, New York 2014-2018
	Beth H. Shaz, MD Chief Medical Officer & Senior Vice President New York Blood Center New York, New York 2014-2021